학술논문
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Document Type
Article
Author
Hahn, N.M.; Zahurak, M.; Rosner, G.L.; Kates, M.R.; Bivalacqua, T.J.; Tran, P.T.; Song, D.Y.; Baras, A.S.; Matoso, A.; Choi, W.; Smith, K.N.; Pardoll, D.M.; Marchionni, L.; McGuire, B.; Grace Phelan, M.; Johnson, B.A.; O'Neal, T.; McConkey, D.J.; O'Donnell, M.A.; Efstathiou, J.A.; Smith, J.; Rose, T.L.; Bjurlin, M.; Lim, E.A.; Drake, C.G.; McKiernan, J.M.; Deutsch, I.; Anderson, C.B.; Lamm, D.L.; Geynisman, D.M.; Plimack, E.R.; Hallman, M.A.; Horwitz, E.M.; Al-Saleem, E.; Chen, D.Y.T.; Greenberg, R.E.; Kutikov, A.; Guo, G.; Masterson, T.A.; Kaimakliotis, H.Z.; Adra, N.
Source
In: European Urology . (European Urology, June 2023, 83(6):486-494)
Subject
Language
English
ISSN
18737560
03022838
03022838